25 XP   0   0   10

Shanghai Haohai Biological
Buy, Hold or Sell?

Let's analyse Shanghai Haohai Biological together

PenkeI guess you are interested in Shanghai Haohai Biological. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Haohai Biological. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanghai Haohai Biological

I send you an email if I find something interesting about Shanghai Haohai Biological.

Quick analysis of Shanghai Haohai Biological (30 sec.)










What can you expect buying and holding a share of Shanghai Haohai Biological? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.39
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$34.85
Expected worth in 1 year
HK$33.57
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
HK$1.79
Return On Investment
4.7%

For what price can you sell your share?

Current Price per Share
HK$38.30
Expected price per share
HK$35.65 - HK$45.85
How sure are you?
50%

1. Valuation of Shanghai Haohai Biological (5 min.)




Live pricePrice per Share (EOD)

HK$38.30

Intrinsic Value Per Share

HK$-13.71 - HK$8.48

Total Value Per Share

HK$21.14 - HK$43.34

2. Growth of Shanghai Haohai Biological (5 min.)




Is Shanghai Haohai Biological growing?

Current yearPrevious yearGrowGrow %
How rich?$761.7m$789.1m-$27.4m-3.6%

How much money is Shanghai Haohai Biological making?

Current yearPrevious yearGrowGrow %
Making money$24.9m$48.6m-$23.7m-95.2%
Net Profit Margin8.6%20.1%--

How much money comes from the company's main activities?

3. Financial Health of Shanghai Haohai Biological (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#71 / 1019

Most Revenue
#50 / 1019

Most Profit
#75 / 1019

Most Efficient
#122 / 1019

What can you expect buying and holding a share of Shanghai Haohai Biological? (5 min.)

Welcome investor! Shanghai Haohai Biological's management wants to use your money to grow the business. In return you get a share of Shanghai Haohai Biological.

What can you expect buying and holding a share of Shanghai Haohai Biological?

First you should know what it really means to hold a share of Shanghai Haohai Biological. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Haohai Biological is HK$38.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Haohai Biological.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Haohai Biological, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$34.85. Based on the TTM, the Book Value Change Per Share is HK$-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.77 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Haohai Biological.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.150.4%0.150.4%0.280.7%0.250.7%0.461.2%
Usd Book Value Change Per Share-0.04-0.1%-0.04-0.1%0.030.1%0.340.9%0.260.7%
Usd Dividend Per Share0.100.3%0.100.3%0.070.2%0.080.2%0.140.4%
Usd Total Gains Per Share0.060.1%0.060.1%0.100.3%0.421.1%0.401.1%
Usd Price Per Share4.70-4.70-6.57-5.65-4.44-
Price to Earnings Ratio32.31-32.31-23.75-24.86-16.26-
Price-to-Total Gains Ratio82.20-82.20-63.20-36.26-24.50-
Price to Book Ratio1.06-1.06-1.46-1.38-1.11-
Price-to-Total Gains Ratio82.20-82.20-63.20-36.26-24.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.88708
Number of shares204
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.100.08
Usd Book Value Change Per Share-0.040.34
Usd Total Gains Per Share0.060.42
Gains per Quarter (204 shares)11.6784.87
Gains per Year (204 shares)46.68339.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
180-343764275329
2160-6784129550668
3241-1011311938251007
4321-13417825811001346
5401-16822532213751685
6481-20127238716502024
7562-23531945119252363
8642-26836651622002702
9722-30241358024753041
10802-33546064527503380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.02.083.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%10.02.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.02.083.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%11.01.00.091.7%

Fundamentals of Shanghai Haohai Biological

About Shanghai Haohai Biological

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, soft contact lens, medical sodium hyaluronate gels, injectors, scalpels, suture needles, and other products; orthopedics products, such as sodium hyaluronate injection and medical chitosan products; and anti-adhesion products, including medical sodium hyaluronate gel, and medical chitosan and collagen sponge products. The company also provides medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; recombinant human epidermal growth factor products; and radio frequency devices and laser equipment. In addition, it is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-03-28 03:20:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shanghai Haohai Biological.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanghai Haohai Biological earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • A Net Profit Margin of 8.6% means that $0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Haohai Biological:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is 8.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY20.1%-11.5%
TTM8.6%5Y19.2%-10.6%
5Y19.2%10Y27.2%-7.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6%-196.9%+205.5%
TTM8.6%-211.2%+219.8%
YOY20.1%-279.3%+299.4%
5Y19.2%-436.8%+456.0%
10Y27.2%-599.3%+626.5%
1.1.2. Return on Assets

Shows how efficient Shanghai Haohai Biological is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • 2.6% Return on Assets means that Shanghai Haohai Biological generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Haohai Biological:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%0.0%
TTM2.6%YOY5.1%-2.4%
TTM2.6%5Y5.3%-2.7%
5Y5.3%10Y10.1%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-13.6%+16.2%
TTM2.6%-12.9%+15.5%
YOY5.1%-11.9%+17.0%
5Y5.3%-14.2%+19.5%
10Y10.1%-16.2%+26.3%
1.1.3. Return on Equity

Shows how efficient Shanghai Haohai Biological is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • 3.3% Return on Equity means Shanghai Haohai Biological generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Haohai Biological:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY6.2%-2.9%
TTM3.3%5Y6.4%-3.1%
5Y6.4%10Y12.2%-5.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%-17.0%+20.3%
TTM3.3%-16.1%+19.4%
YOY6.2%-15.4%+21.6%
5Y6.4%-20.0%+26.4%
10Y12.2%-21.1%+33.3%

1.2. Operating Efficiency of Shanghai Haohai Biological.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanghai Haohai Biological is operating .

  • Measures how much profit Shanghai Haohai Biological makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • An Operating Margin of 7.8% means the company generated $0.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Haohai Biological:

  • The MRQ is 7.8%. The company is operating less efficient.
  • The TTM is 7.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.8%TTM7.8%0.0%
TTM7.8%YOY11.3%-3.4%
TTM7.8%5Y13.9%-6.1%
5Y13.9%10Y25.0%-11.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8%-282.4%+290.2%
TTM7.8%-225.8%+233.6%
YOY11.3%-288.4%+299.7%
5Y13.9%-475.2%+489.1%
10Y25.0%-624.7%+649.7%
1.2.2. Operating Ratio

Measures how efficient Shanghai Haohai Biological is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are $1.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Haohai Biological:

  • The MRQ is 1.207. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.207. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.207TTM1.2070.000
TTM1.207YOY1.150+0.057
TTM1.2075Y1.100+0.107
5Y1.10010Y0.953+0.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2072.994-1.787
TTM1.2073.247-2.040
YOY1.1503.766-2.616
5Y1.1005.675-4.575
10Y0.9537.857-6.904

1.3. Liquidity of Shanghai Haohai Biological.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanghai Haohai Biological is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.91 means the company has $6.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Haohai Biological:

  • The MRQ is 6.908. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.908. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.908TTM6.9080.000
TTM6.908YOY7.619-0.711
TTM6.9085Y7.871-0.962
5Y7.87110Y7.221+0.649
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9083.930+2.978
TTM6.9084.251+2.657
YOY7.6195.436+2.183
5Y7.8716.045+1.826
10Y7.2216.383+0.838
1.3.2. Quick Ratio

Measures if Shanghai Haohai Biological is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • A Quick Ratio of 5.73 means the company can pay off $5.73 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Haohai Biological:

  • The MRQ is 5.731. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.731. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.731TTM5.7310.000
TTM5.731YOY6.740-1.009
TTM5.7315Y6.999-1.268
5Y6.99910Y6.144+0.855
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7313.629+2.102
TTM5.7314.065+1.666
YOY6.7405.390+1.350
5Y6.9995.993+1.006
10Y6.1446.277-0.133

1.4. Solvency of Shanghai Haohai Biological.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Haohai Biological assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Haohai Biological to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.20 means that Shanghai Haohai Biological assets are financed with 20.0% credit (debt) and the remaining percentage (100% - 20.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Haohai Biological:

  • The MRQ is 0.200. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.200. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.200TTM0.2000.000
TTM0.200YOY0.178+0.022
TTM0.2005Y0.153+0.047
5Y0.15310Y0.161-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2000.332-0.132
TTM0.2000.333-0.133
YOY0.1780.268-0.090
5Y0.1530.366-0.213
10Y0.1610.390-0.229
1.4.2. Debt to Equity Ratio

Measures if Shanghai Haohai Biological is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • A Debt to Equity ratio of 25.0% means that company has $0.25 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Haohai Biological:

  • The MRQ is 0.250. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.250. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.2500.000
TTM0.250YOY0.216+0.033
TTM0.2505Y0.185+0.065
5Y0.18510Y0.198-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2500.380-0.130
TTM0.2500.389-0.139
YOY0.2160.334-0.118
5Y0.1850.432-0.247
10Y0.1980.465-0.267

2. Market Valuation of Shanghai Haohai Biological

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Shanghai Haohai Biological generates.

  • Above 15 is considered overpriced but always compare Shanghai Haohai Biological to the Biotechnology industry mean.
  • A PE ratio of 32.31 means the investor is paying $32.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Haohai Biological:

  • The EOD is 33.578. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.306. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.306. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD33.578MRQ32.306+1.271
MRQ32.306TTM32.3060.000
TTM32.306YOY23.748+8.559
TTM32.3065Y24.858+7.449
5Y24.85810Y16.264+8.593
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD33.578-2.426+36.004
MRQ32.306-2.552+34.858
TTM32.306-2.656+34.962
YOY23.748-4.143+27.891
5Y24.858-6.252+31.110
10Y16.264-6.108+22.372
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Haohai Biological:

  • The EOD is -70.584. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -67.911. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -67.911. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-70.584MRQ-67.911-2.672
MRQ-67.911TTM-67.9110.000
TTM-67.911YOY119.175-187.086
TTM-67.9115Y7.593-75.504
5Y7.59310Y10.294-2.701
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-70.584-3.199-67.385
MRQ-67.911-3.259-64.652
TTM-67.911-3.552-64.359
YOY119.175-5.617+124.792
5Y7.593-8.326+15.919
10Y10.294-8.689+18.983
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanghai Haohai Biological is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.06 means the investor is paying $1.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Haohai Biological:

  • The EOD is 1.099. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.057. Based on the equity, the company is underpriced. +1
  • The TTM is 1.057. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.099MRQ1.057+0.042
MRQ1.057TTM1.0570.000
TTM1.057YOY1.464-0.407
TTM1.0575Y1.376-0.319
5Y1.37610Y1.107+0.270
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0991.947-0.848
MRQ1.0572.116-1.059
TTM1.0572.095-1.038
YOY1.4642.836-1.372
5Y1.3763.443-2.067
10Y1.1073.791-2.684
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanghai Haohai Biological compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.322-0.3220%0.274-218%2.641-112%2.063-116%
Book Value Per Share--34.85434.8540%35.177-1%32.513+7%34.234+2%
Current Ratio--6.9086.9080%7.619-9%7.871-12%7.221-4%
Debt To Asset Ratio--0.2000.2000%0.178+12%0.153+30%0.161+24%
Debt To Equity Ratio--0.2500.2500%0.216+15%0.185+35%0.198+26%
Dividend Per Share--0.7700.7700%0.541+42%0.619+24%1.103-30%
Eps--1.1411.1410%2.169-47%1.954-42%3.624-69%
Free Cash Flow Per Share---0.543-0.5430%0.432-226%0.321-269%1.408-139%
Free Cash Flow To Equity Per Share---2.365-2.3650%-0.992-58%1.011-334%7.507-132%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.481--------
Intrinsic Value_10Y_min---13.711--------
Intrinsic Value_1Y_max--1.290--------
Intrinsic Value_1Y_min---0.276--------
Intrinsic Value_3Y_max--3.541--------
Intrinsic Value_3Y_min---1.786--------
Intrinsic Value_5Y_max--5.387--------
Intrinsic Value_5Y_min---4.331--------
Market Cap1133626380.000-457%6311336350.0006311336350.0000%9054838150.000-30%7664723880.000-18%5190056362.000+22%
Net Profit Margin--0.0860.0860%0.201-57%0.192-55%0.272-68%
Operating Margin--0.0780.0780%0.113-31%0.139-44%0.250-69%
Operating Ratio--1.2071.2070%1.150+5%1.100+10%0.953+27%
Pb Ratio1.099+4%1.0571.0570%1.464-28%1.376-23%1.107-4%
Pe Ratio33.578+4%32.30632.3060%23.748+36%24.858+30%16.264+99%
Price Per Share38.300+4%36.85036.8500%51.500-28%44.270-17%34.775+6%
Price To Free Cash Flow Ratio-70.584-4%-67.911-67.9110%119.175-157%7.593-994%10.294-760%
Price To Total Gains Ratio85.433+4%82.19882.1980%63.197+30%36.262+127%24.497+236%
Quick Ratio--5.7315.7310%6.740-15%6.999-18%6.144-7%
Return On Assets--0.0260.0260%0.051-48%0.053-51%0.101-74%
Return On Equity--0.0330.0330%0.062-47%0.064-49%0.122-73%
Total Gains Per Share--0.4480.4480%0.815-45%3.260-86%3.166-86%
Usd Book Value--761716397.343761716397.3430%789183227.547-3%719050652.192+6%496149545.774+54%
Usd Book Value Change Per Share---0.041-0.0410%0.035-218%0.337-112%0.263-116%
Usd Book Value Per Share--4.4474.4470%4.489-1%4.149+7%4.368+2%
Usd Dividend Per Share--0.0980.0980%0.069+42%0.079+24%0.141-30%
Usd Eps--0.1460.1460%0.277-47%0.249-42%0.462-69%
Usd Free Cash Flow---11858479.204-11858479.2040%9694996.003-222%6618272.329-279%12378071.540-196%
Usd Free Cash Flow Per Share---0.069-0.0690%0.055-226%0.041-269%0.180-139%
Usd Free Cash Flow To Equity Per Share---0.302-0.3020%-0.127-58%0.129-334%0.958-132%
Usd Market Cap144650726.088-457%805326518.260805326518.2600%1155397347.940-30%978018767.088-18%662251191.791+22%
Usd Price Per Share4.887+4%4.7024.7020%6.571-28%5.649-17%4.437+6%
Usd Profit--24927779.69024927779.6900%48653025.718-49%42766743.613-42%39008984.765-36%
Usd Revenue--290541580.626290541580.6260%241738272.732+20%229824073.096+26%167082024.315+74%
Usd Total Gains Per Share--0.0570.0570%0.104-45%0.416-86%0.404-86%
 EOD+3 -5MRQTTM+0 -0YOY+7 -285Y+10 -2510Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of Shanghai Haohai Biological based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1533.578
Price to Book Ratio (EOD)Between0-11.099
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.078
Quick Ratio (MRQ)Greater than15.731
Current Ratio (MRQ)Greater than16.908
Debt to Asset Ratio (MRQ)Less than10.200
Debt to Equity Ratio (MRQ)Less than10.250
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.026
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Shanghai Haohai Biological based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.513
Ma 20Greater thanMa 5040.113
Ma 50Greater thanMa 10037.593
Ma 100Greater thanMa 20038.911
OpenGreater thanClose38.500
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Other Stockholders Equity  46,68117,77164,452-25,55638,89612,92251,818-102,717-50,899
Minority Interest  242,411-27,455214,95548,627263,582-258,2235,359-16,034-10,675



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,892,399
Total Liabilities1,377,790
Total Stockholder Equity5,514,609
 As reported
Total Liabilities 1,377,790
Total Stockholder Equity+ 5,514,609
Total Assets = 6,892,399

Assets

Total Assets6,892,399
Total Current Assets3,532,116
Long-term Assets3,360,283
Total Current Assets
Cash And Cash Equivalents 2,541,715
Short-term Investments 6,749
Net Receivables 381,526
Inventory 485,239
Other Current Assets 104,726
Total Current Assets  (as reported)3,532,116
Total Current Assets  (calculated)3,519,955
+/- 12,161
Long-term Assets
Property Plant Equipment 1,409,551
Goodwill 411,199
Intangible Assets 620,416
Other Assets 148,391
Long-term Assets  (as reported)3,360,283
Long-term Assets  (calculated)2,589,557
+/- 770,726

Liabilities & Shareholders' Equity

Total Current Liabilities511,275
Long-term Liabilities478,741
Total Stockholder Equity5,514,609
Total Current Liabilities
Short-term Debt 5,314
Short Long Term Debt 13,019
Accounts payable 54,533
Other Current Liabilities 197,137
Total Current Liabilities  (as reported)511,275
Total Current Liabilities  (calculated)270,003
+/- 241,272
Long-term Liabilities
Long term Debt Total 304,440
Capital Lease Obligations Min Short Term Debt55,945
Long-term Liabilities Other 220,560
Long-term Liabilities  (as reported)478,741
Long-term Liabilities  (calculated)580,945
+/- 102,204
Total Stockholder Equity
Retained Earnings 2,458,424
Capital Surplus 3,003,117
Total Stockholder Equity (as reported)5,514,609
Total Stockholder Equity (calculated)5,461,541
+/- 53,068
Other
Capital Stock174,130
Cash and Short Term Investments 2,541,715
Common Stock Shares Outstanding 171,271
Liabilities and Stockholders Equity 6,892,399
Net Invested Capital 5,571,608
Net Tangible Assets 4,482,994
Net Working Capital 3,020,841
Property Plant and Equipment Gross 1,907,442



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
331,763
448,037
621,178
751,903
2,821,910
3,693,412
4,109,323
4,436,352
6,151,871
6,298,705
6,950,356
6,892,399
6,892,3996,950,3566,298,7056,151,8714,436,3524,109,3233,693,4122,821,910751,903621,178448,037331,763
   > Total Current Assets 
0
0
297,448
347,355
2,372,054
2,488,163
2,385,970
2,293,891
3,945,375
3,809,959
3,712,586
3,532,116
3,532,1163,712,5863,809,9593,945,3752,293,8912,385,9702,488,1632,372,054347,355297,44800
       Cash And Cash Equivalents 
121,687
160,814
197,137
181,341
2,177,787
2,010,255
1,797,420
1,438,407
3,222,508
3,092,603
2,900,788
2,541,715
2,541,7152,900,7883,092,6033,222,5081,438,4071,797,4202,010,2552,177,787181,341197,137160,814121,687
       Short-term Investments 
5,868
8,843
8,739
19,735
12,343
102,633
57,637
81,283
0
15,145
6,376
6,749
6,7496,37615,145081,28357,637102,63312,34319,7358,7398,8435,868
       Net Receivables 
23,185
29,480
43,820
65,195
91,287
235,153
333,042
471,607
428,949
333,528
370,504
381,526
381,526370,504333,528428,949471,607333,042235,15391,28765,19543,82029,48023,185
       Other Current Assets 
2,030
5,286
5,148
4,720
12,574
22,169
22,957
165,549
37,428
94,684
56,270
104,726
104,72656,27094,68437,428165,54922,95722,16912,5744,7205,1485,2862,030
   > Long-term Assets 
0
0
0
0
0
1,205,249
1,689,329
2,142,461
2,206,496
2,488,746
3,237,770
3,360,283
3,360,2833,237,7702,488,7462,206,4962,142,4611,689,3291,205,24900000
       Property Plant Equipment 
88,379
145,757
270,625
352,003
396,595
474,754
585,757
703,852
1,111,785
1,041,685
1,248,921
1,409,551
1,409,5511,248,9211,041,6851,111,785703,852585,757474,754396,595352,003270,625145,75788,379
       Goodwill 
0
0
0
0
0
292,084
331,841
332,003
333,493
385,490
406,901
411,199
411,199406,901385,490333,493332,003331,841292,08400000
       Long Term Investments 
0
0
0
0
11,202
64,226
186,107
591,600
0
0
0
0
0000591,600186,10764,22611,2020000
       Intangible Assets 
8,214
7,436
5,142
4,050
3,262
295,406
449,514
428,394
430,609
404,332
613,397
620,416
620,416613,397404,332430,609428,394449,514295,4063,2624,0505,1427,4368,214
       Long-term Assets Other 
0
0
0
0
0
39,078
10,000
30,877
14,257
36,845
130,932
25,238
25,238130,93236,84514,25730,87710,00039,07800000
> Total Liabilities 
56,648
58,980
90,600
157,743
159,999
789,420
908,761
824,841
697,091
564,460
1,236,895
1,377,790
1,377,7901,236,895564,460697,091824,841908,761789,420159,999157,74390,60058,98056,648
   > Total Current Liabilities 
55,474
54,702
76,128
139,239
140,993
536,155
477,756
451,317
359,967
433,761
487,272
511,275
511,275487,272433,761359,967451,317477,756536,155140,993139,23976,12854,70255,474
       Short-term Debt 
0
0
0
0
0
26,666
19,888
20,269
14,637
78,691
48,781
5,314
5,31448,78178,69114,63720,26919,88826,66600000
       Short Long Term Debt 
0
0
0
0
0
26,666
19,888
20,269
14,637
87,708
42,421
13,019
13,01942,42187,70814,63720,26919,88826,66600000
       Accounts payable 
5,017
6,292
6,904
8,790
4,794
19,686
39,009
41,183
36,786
28,032
46,264
54,533
54,53346,26428,03236,78641,18339,00919,6864,7948,7906,9046,2925,017
       Other Current Liabilities 
50,457
48,410
69,224
130,449
95,463
411,889
319,154
270,916
195,640
193,443
200,494
197,137
197,137200,494193,443195,640270,916319,154411,88995,463130,44969,22448,41050,457
   > Long-term Liabilities 
0
0
0
0
0
171,397
230,838
149,588
138,551
130,699
402,798
478,741
478,741402,798130,699138,551149,588230,838171,39700000
       Long term Debt Total 
0
0
0
0
0
0
17,596
16,386
24,002
20,373
39,493
304,440
304,44039,49320,37324,00216,38617,596000000
       Other Liabilities 
0
3,296
13,825
17,743
15,483
171,397
228,707
133,202
114,549
110,326
363,305
394,861
394,861363,305110,326114,549133,202228,707171,39715,48317,74313,8253,2960
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
4,700
0
0
004,700000000000
> Total Stockholder Equity
275,115
389,057
530,578
594,160
2,661,911
2,903,992
3,200,562
3,611,511
5,454,780
5,490,751
5,713,461
5,514,609
5,514,6095,713,4615,490,7515,454,7803,611,5113,200,5622,903,9922,661,911594,160530,578389,057275,115
   Common Stock
120,000
120,000
120,000
120,000
160,045
160,045
160,045
160,045
177,845
177,207
175,822
174,130
174,130175,822177,207177,845160,045160,045160,045160,045120,000120,000120,000120,000
   Retained Earnings 
138,961
252,903
394,424
458,006
731,480
972,514
1,258,812
1,637,957
1,935,540
2,046,072
2,398,648
2,458,424
2,458,4242,398,6482,046,0721,935,5401,637,9571,258,812972,514731,480458,006394,424252,903138,961
   Capital Surplus 
0
0
0
0
1,770,386
1,770,386
1,770,386
1,770,386
3,281,855
3,259,803
3,091,122
3,003,117
3,003,1173,091,1223,259,8033,281,8551,770,3861,770,3861,770,3861,770,3860000
   Treasury Stock00-28,263000000000
   Other Stockholders Equity 
0
0
0
0
0
1,047
11,319
43,123
59,540
35,932
47,869
-47,020
-47,02047,86935,93259,54043,12311,3191,04700000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,502,669
Cost of Revenue-744,559
Gross Profit1,758,1101,758,110
 
Operating Income (+$)
Gross Profit1,758,110
Operating Expense-2,113,400
Operating Income389,269-355,290
 
Operating Expense (+$)
Research Development215,125
Selling General Administrative1,202,000
Selling And Marketing Expenses-
Operating Expense2,113,4001,417,126
 
Net Interest Income (+$)
Interest Income83,239
Interest Expense-9,219
Other Finance Cost-1,895
Net Interest Income72,124
 
Pretax Income (+$)
Operating Income389,269
Net Interest Income72,124
Other Non-Operating Income Expenses-
Income Before Tax (EBT)415,564389,269
EBIT - interestExpense = -9,219
345,523
354,743
Interest Expense9,219
Earnings Before Interest and Taxes (EBIT)-424,783
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax415,564
Tax Provision-64,525
Net Income From Continuing Ops351,039351,039
Net Income345,523
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--72,124
 

Technical Analysis of Shanghai Haohai Biological
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Haohai Biological. The general trend of Shanghai Haohai Biological is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Haohai Biological's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Haohai Biological.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 43.40 < 45.55 < 45.85.

The bearish price targets are: 36.90 > 35.90 > 35.65.

Tweet this
Shanghai Haohai Biological Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Haohai Biological. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Haohai Biological Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Haohai Biological. The current macd is 0.13886979.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Haohai Biological price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shanghai Haohai Biological. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shanghai Haohai Biological price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanghai Haohai Biological Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Haohai Biological Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Haohai Biological. The current adx is 16.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Shanghai Haohai Biological shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Shanghai Haohai Biological Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Haohai Biological. The current sar is 37.41.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shanghai Haohai Biological Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Haohai Biological. The current rsi is 45.51. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Shanghai Haohai Biological Daily Relative Strength Index (RSI) ChartShanghai Haohai Biological Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Haohai Biological. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Haohai Biological price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Shanghai Haohai Biological Daily Stochastic Oscillator ChartShanghai Haohai Biological Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Haohai Biological. The current cci is -112.55411255.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Shanghai Haohai Biological Daily Commodity Channel Index (CCI) ChartShanghai Haohai Biological Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Haohai Biological. The current cmo is -18.82662615.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shanghai Haohai Biological Daily Chande Momentum Oscillator (CMO) ChartShanghai Haohai Biological Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Haohai Biological. The current willr is -72.54901961.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shanghai Haohai Biological is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shanghai Haohai Biological Daily Williams %R ChartShanghai Haohai Biological Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Haohai Biological.

Shanghai Haohai Biological Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Haohai Biological. The current atr is 1.51139977.

Shanghai Haohai Biological Daily Average True Range (ATR) ChartShanghai Haohai Biological Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Haohai Biological. The current obv is 18,557,632.

Shanghai Haohai Biological Daily On-Balance Volume (OBV) ChartShanghai Haohai Biological Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Haohai Biological. The current mfi is 30.36.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shanghai Haohai Biological Daily Money Flow Index (MFI) ChartShanghai Haohai Biological Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Haohai Biological.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Shanghai Haohai Biological Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Haohai Biological based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.513
Ma 20Greater thanMa 5040.113
Ma 50Greater thanMa 10037.593
Ma 100Greater thanMa 20038.911
OpenGreater thanClose38.500
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanghai Haohai Biological with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Haohai Biological? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Haohai Biological? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Haohai Biological

I send you an email if I find something interesting about Shanghai Haohai Biological.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Haohai Biological.

Receive notifications about Shanghai Haohai Biological in your mailbox!